New York Times: Pfizer and Moderna extend vaccine studies to 5-11 year olds
Von der Leyen: agreement with Pfizer for 50 million additional doses
Covid-19, study confirms: mRNA vaccines reduce the severity of symptoms
Vaccines, Aifa approves the use of Moderna for 12-17 year olds
Covid-19, the Pfizer vaccine has been adapted against the Delta variant
Usa, Pfizer seeks authorization for third dose of vaccine
01 August 2021
The prices of Pfizer and Moderna's Covid vaccines increase in the latest supply contracts with the European Union.
The Financial Times reports this, citing excerpts from the contracts taken into consideration.
The new price for Pfizer vaccines is 19.50 euros against the 15.50 of the previous supply, while that of Moderna instead rises to 25.50 dollars per dose, above the 22.60 dollars of the previous agreement but less than 28, $ 50 initially planned after the order was expanded.
The agreements, signed this year for a total of up to 2.1 billion doses by 2023, have been renegotiated - writes the FT - after the phase 3 tests.Keywords: